Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion type Assertion NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_head.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion description "[We investigated whether oral administration of human commensal bacteria engineered to secrete GLP-1(1-37) could ameliorate hyperglycemia in a rat model of diabetes by reprogramming intestinal cells into glucose-responsive insulin-secreting cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion evidence source_evidence_literature NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion SIO_000772 25626737 NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion wasDerivedFrom befree-2016 NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.
- NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_assertion wasGeneratedBy ECO_0000203 NP1258902.RAF_FMytGxrHnLD8g4UBC6A2JMGkspk8_1-ouiv3v57zU130_provenance.